Cargando…

‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts

BACKGROUND: Drug alerts designed for health and community workforces have potential to avert acute harms associated with unpredictable illicit drug markets, by preparing workers to respond to unusual drug-related events, and distribute information to service users. However, the design of such alerts...

Descripción completa

Detalles Bibliográficos
Autores principales: Volpe, Isabelle, Brien, Rita, Grigg, Jasmin, Tzanetis, Stephanie, Crawford, Sione, Lyons, Tom, Lee, Nicole, McKinnon, Ginny, Hughes, Caitlin, Eade, Alan, Barratt, Monica J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829230/
https://www.ncbi.nlm.nih.gov/pubmed/36624508
http://dx.doi.org/10.1186/s12954-022-00716-3
_version_ 1784867424923811840
author Volpe, Isabelle
Brien, Rita
Grigg, Jasmin
Tzanetis, Stephanie
Crawford, Sione
Lyons, Tom
Lee, Nicole
McKinnon, Ginny
Hughes, Caitlin
Eade, Alan
Barratt, Monica J.
author_facet Volpe, Isabelle
Brien, Rita
Grigg, Jasmin
Tzanetis, Stephanie
Crawford, Sione
Lyons, Tom
Lee, Nicole
McKinnon, Ginny
Hughes, Caitlin
Eade, Alan
Barratt, Monica J.
author_sort Volpe, Isabelle
collection PubMed
description BACKGROUND: Drug alerts designed for health and community workforces have potential to avert acute harms associated with unpredictable illicit drug markets, by preparing workers to respond to unusual drug-related events, and distribute information to service users. However, the design of such alerts is complicated by diverse needs of individuals, and broader socio-political contexts. Here, we discuss the tensions that arose in the process of co-designing drug alert templates with health and community workers. METHODS: We conducted five in-depth digital co-design workshops with 31 workers employed in alcohol and other drug and urgent care settings. Our approach to analysis was informed by Iterative Categorisation and reflexive thematic analysis methods. RESULTS: We identified five key tensions. First, there is a need to provide comprehensive information to meet the information needs of a diverse group of workers with varying knowledge levels, while also designing alerts to be clear, concise, and relevant to the work of individuals. Second, it is important that alerts do not create ‘information overload’; however, it is also important that information should be available to those who want it. Third, alert design and dissemination must be perceived to be credible, to avoid ‘alert scepticism’; however, credibility is challenging to develop in a broader context of criminalisation, stigmatisation, and sensationalism. Fourth, alerts must be carefully designed to achieve ‘intended effects’ and avoid unintended effects, while acknowledging that it is impossible to control all potential effects. Finally, while alerts may be intended for an audience of health and community workers, people who use drugs are the end-users and must be kept front of mind in the design process. CONCLUSIONS: The co-design process revealed complexities in designing drug alerts, particularly in the context of stigmatised illicit drug use, workforce diversity, and dissemination strategies. This study has highlighted the value of developing these important risk communication tools with their target audiences to ensure that they are relevant, useful, and impactful. The findings have informed the development of our drug alert prototypes and provide local context to complement existing best-practice risk-communications literature. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12954-022-00716-3.
format Online
Article
Text
id pubmed-9829230
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98292302023-01-10 ‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts Volpe, Isabelle Brien, Rita Grigg, Jasmin Tzanetis, Stephanie Crawford, Sione Lyons, Tom Lee, Nicole McKinnon, Ginny Hughes, Caitlin Eade, Alan Barratt, Monica J. Harm Reduct J Research BACKGROUND: Drug alerts designed for health and community workforces have potential to avert acute harms associated with unpredictable illicit drug markets, by preparing workers to respond to unusual drug-related events, and distribute information to service users. However, the design of such alerts is complicated by diverse needs of individuals, and broader socio-political contexts. Here, we discuss the tensions that arose in the process of co-designing drug alert templates with health and community workers. METHODS: We conducted five in-depth digital co-design workshops with 31 workers employed in alcohol and other drug and urgent care settings. Our approach to analysis was informed by Iterative Categorisation and reflexive thematic analysis methods. RESULTS: We identified five key tensions. First, there is a need to provide comprehensive information to meet the information needs of a diverse group of workers with varying knowledge levels, while also designing alerts to be clear, concise, and relevant to the work of individuals. Second, it is important that alerts do not create ‘information overload’; however, it is also important that information should be available to those who want it. Third, alert design and dissemination must be perceived to be credible, to avoid ‘alert scepticism’; however, credibility is challenging to develop in a broader context of criminalisation, stigmatisation, and sensationalism. Fourth, alerts must be carefully designed to achieve ‘intended effects’ and avoid unintended effects, while acknowledging that it is impossible to control all potential effects. Finally, while alerts may be intended for an audience of health and community workers, people who use drugs are the end-users and must be kept front of mind in the design process. CONCLUSIONS: The co-design process revealed complexities in designing drug alerts, particularly in the context of stigmatised illicit drug use, workforce diversity, and dissemination strategies. This study has highlighted the value of developing these important risk communication tools with their target audiences to ensure that they are relevant, useful, and impactful. The findings have informed the development of our drug alert prototypes and provide local context to complement existing best-practice risk-communications literature. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12954-022-00716-3. BioMed Central 2023-01-09 /pmc/articles/PMC9829230/ /pubmed/36624508 http://dx.doi.org/10.1186/s12954-022-00716-3 Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Volpe, Isabelle
Brien, Rita
Grigg, Jasmin
Tzanetis, Stephanie
Crawford, Sione
Lyons, Tom
Lee, Nicole
McKinnon, Ginny
Hughes, Caitlin
Eade, Alan
Barratt, Monica J.
‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts
title ‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts
title_full ‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts
title_fullStr ‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts
title_full_unstemmed ‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts
title_short ‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts
title_sort ‘we don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829230/
https://www.ncbi.nlm.nih.gov/pubmed/36624508
http://dx.doi.org/10.1186/s12954-022-00716-3
work_keys_str_mv AT volpeisabelle wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts
AT brienrita wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts
AT griggjasmin wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts
AT tzanetisstephanie wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts
AT crawfordsione wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts
AT lyonstom wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts
AT leenicole wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts
AT mckinnonginny wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts
AT hughescaitlin wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts
AT eadealan wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts
AT barrattmonicaj wedontliveinaharmreductionworldweliveinaprohibitionworldtensionsarisinginthedesignofdrugalerts